CoChat

Profound Alterations of Intestinal Microbiota following a Single Dose of Clindamycin Results in Sustained Susceptibility to Clostridium difficile-Induced Colitis

Open access
Buffie, Charlie G., Jarchum, Irene, Equinda, Michele, Lipuma, Lauren, Gobourne, Asia, Viale, Agnes, Ubeda, Carles, Xavier, Joao, Pamer, Eric G. · 2012 · Infection and Immunity

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

Abstract

Antibiotic-induced changes in the intestinal microbiota predispose mammalian hosts to infection with antibiotic-resistant pathogens. Clostridium difficile is a Gram-positive intestinal pathogen that causes colitis and diarrhea in patients following antibiotic treatment. Clindamycin predisposes patients to C. difficile colitis. Here, we have used Roche-454 16S rRNA gene pyrosequencing to longitudinally characterize the intestinal microbiota of mice following clindamycin treatment in the presence or absence of C. difficile infection. We show that a single dose of clindamycin markedly reduces the diversity of the intestinal microbiota for at least 28 days, with an enduring loss of ca. 90% of normal microbial taxa from the cecum. Loss of microbial complexity results in dramatic sequential expansion and contraction of a subset of bacterial taxa that are minor contributors to the microbial consortium prior to antibiotic treatment. Inoculation of clindamycin-treated mice with C. difficile (VPI 10463) spores results in rapid development of diarrhea and colitis, with a 4- to 5-day period of profound weight loss and an associated 40 to 50% mortality rate. Recovering mice resolve diarrhea and regain weight but remain highly infected with toxin-producing vegetative C. difficile bacteria and, in comparison to the acute stage of infection, have persistent, albeit ameliorated cecal and colonic inflammation. The microbiota of "recovered" mice remains highly restricted, and mice remain susceptible to C. difficile infection at least 10 days following clindamycin, suggesting that resolution of diarrhea and weight gain may result from the activation of mucosal immune defenses.

Overview

Integrity signals

Registry

Crossref · 10.1128/iai.05496-11

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Research works printed but not linked: 2

  1. 10.3201/eid1205.051064 · doi:10.3201/eid1205.051064 · Paper page
  2. 10.1017/S0195941700026072 · doi:10.1017/s0195941700026072 · Paper page

Cited by

See all 597

Metadata

Authors
Buffie, C. G., Jarchum, I., Equinda, M., Lipuma, L., Gobourne, A., Viale, A., Ubeda, C., Xavier, J., & Pamer, E. G.
Affiliations
  • Memorial Sloan Kettering Cancer Center (US)
  • Infectious Diseases Service, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
  • Department of Medicine, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Venue
Infection and Immunity
Published
2012-01
Volume
80
Issue
1
Pages
62-73
ISSN
  • 0019-9567 (ISSN-L)
  • 1098-5522
OpenAlex
W2149711482
Cited by
596
References
42
Citations by year
2026: 19 · 2025: 33 · 2024: 53 · 2023: 46 · 2022: 30 · 2021: 53 · 2020: 55 · 2019: 49 · 2018: 47 · 2017: 40 · 2016: 52 · 2015: 43 · 2014: 36 · 2013: 25 · 2012: 14
FWCI
16.18
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Infection and Immunity (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of General Medical Sciences (T32GM007739)
  • National Institute of Allergy and Infectious Diseases (1R01 AI42135, R01AI042135)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Keywords
gut microbiota, clindamycin, Clostridium difficile, C. difficile colitis, antibiotic-induced dysbiosis, microbial diversity, cecal microbiota, weight loss, 16S rRNA gene pyrosequencing
MeSH terms
Animals, Anti-Bacterial Agents, Bacteria, Clindamycin, Clostridium Infections, Colitis, Diarrhea, Disease Susceptibility, Female, Longitudinal Studies, Mice, Inbred C57BL, Time Factors, Survival Analysis, Clostridioides difficile, Sequence Analysis, DNA, Gastrointestinal Tract, Biodiversity, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Profound Alterations of Intestinal Microbiota following a Single Dose of Clindamycin Results in Sustained Susceptibility to Clostridium difficile-Induced Colitis. https://app.cochat.ai/papers/10.1128/iai.05496-11
The paper
Buffie, C. G., Jarchum, I., Equinda, M., Lipuma, L., Gobourne, A., Viale, A., Ubeda, C., Xavier, J., & Pamer, E. G. (2012). Profound Alterations of Intestinal Microbiota following a Single Dose of Clindamycin Results in Sustained Susceptibility to Clostridium difficile-Induced Colitis. Infection and Immunity. https://doi.org/10.1128/iai.05496-11

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.